149 related articles for article (PubMed ID: 37476736)
1. Retracted: Application Value of Contrast-Enhanced Ultrasound Combined with Enhanced MR Scanning in Patients with Intrahepatic Cholangiocarcinoma.
Healthcare Engineering JO
J Healthc Eng; 2023; 2023():9876728. PubMed ID: 37476736
[TBL] [Abstract][Full Text] [Related]
2. Application Value of Contrast-Enhanced Ultrasound Combined with Enhanced MR Scanning in Patients with Intrahepatic Cholangiocarcinoma.
Zhang M; Liu Y; Han L; Zhang G
J Healthc Eng; 2022; 2022():6402646. PubMed ID: 35399854
[TBL] [Abstract][Full Text] [Related]
3. Retracted: Expression of Tspan8 in Patients with Intrahepatic Cholangiocarcinoma and Its Relationship with Clinicopathological Features and Prognosis.
And Alternative Medicine EC
Evid Based Complement Alternat Med; 2023; 2023():9834798. PubMed ID: 37387978
[TBL] [Abstract][Full Text] [Related]
4. Retracted: Distinctive Metabolism-Associated Gene Clusters That Are Also Prognostic in Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma.
Longevity OMAC
Oxid Med Cell Longev; 2023; 2023():9815947. PubMed ID: 37565164
[TBL] [Abstract][Full Text] [Related]
5. Retracted: Association between Immunohistochemistry Markers and Tumor Features and Their Diagnostic and Prognostic Values in Intrahepatic Cholangiocarcinoma.
Methods In Medicine CAM
Comput Math Methods Med; 2023; 2023():9837859. PubMed ID: 37475935
[TBL] [Abstract][Full Text] [Related]
6. Retracted: Application of Contrast-Enhanced Ultrasound Combined with Elastic Imaging Technology in Differential Diagnosis of Salivary Gland Tumors.
Healthcare Engineering JO
J Healthc Eng; 2023; 2023():9862578. PubMed ID: 37860416
[TBL] [Abstract][Full Text] [Related]
7. Retracted: The Application Value of SMI Technology and Contrast-Enhanced Ultrasound in the Differential Diagnosis of Benign and Malignant Thyroid Nodules.
Imaging CMM
Contrast Media Mol Imaging; 2023; 2023():9867806. PubMed ID: 37829314
[TBL] [Abstract][Full Text] [Related]
8. Retracted: Evaluation of Angiogenesis and Pathological Classification of Extrahepatic Cholangiocarcinoma by Dynamic MR Imaging for E-Healthcare.
Healthcare Engineering JO
J Healthc Eng; 2023; 2023():9789030. PubMed ID: 37946889
[TBL] [Abstract][Full Text] [Related]
9. MR imaging of intrahepatic cholangiocarcinoma with pathologic correlation.
Maetani Y; Itoh K; Watanabe C; Shibata T; Ametani F; Yamabe H; Konishi J
AJR Am J Roentgenol; 2001 Jun; 176(6):1499-507. PubMed ID: 11373220
[TBL] [Abstract][Full Text] [Related]
10. Intrahepatic cholangiocarcinoma: spin-echo and contrast-enhanced dynamic MR imaging.
Fan ZM; Yamashita Y; Harada M; Baba Y; Yamamoto H; Matsukawa T; Arakawa A; Miyazaki T; Takahashi M
AJR Am J Roentgenol; 1993 Aug; 161(2):313-7. PubMed ID: 8392787
[TBL] [Abstract][Full Text] [Related]
11. Retracted: Clinical Value of Contrast-Enhanced Ultrasound in Breast Cancer Diagnosis.
Methods In Medicine CAM
Comput Math Methods Med; 2023; 2023():9769373. PubMed ID: 38094336
[TBL] [Abstract][Full Text] [Related]
12. Contribution of contrast-enhanced sonography in the detection of intrahepatic cholangiocarcinoma.
Kong WT; Wang WP; Zhang WW; Qiu YD; Ding H; Huang BJ
J Ultrasound Med; 2014 Feb; 33(2):215-20. PubMed ID: 24449723
[TBL] [Abstract][Full Text] [Related]
13. Retracted: Clinical Study of Virtual Reality Augmented Technology Combined with Contrast-Enhanced Ultrasound in the Assessment of Thyroid Cancer.
Healthcare Engineering JO
J Healthc Eng; 2023; 2023():9861340. PubMed ID: 37388125
[TBL] [Abstract][Full Text] [Related]
14. Retracted: Diagnosis of Chronic Kidney Disease by Three-Dimensional Contrast-Enhanced Ultrasound Combined with Augmented Reality Medical Technology.
Healthcare Engineering JO
J Healthc Eng; 2023; 2023():9846286. PubMed ID: 37860415
[TBL] [Abstract][Full Text] [Related]
15. Contrast-enhanced MR imaging of intrahepatic cholangiocarcinoma.
Adjei ON; Tamura S; Sugimura H; Kihara Y; Yuuki Y; Kakitsubata S; Watanabe K
Clin Radiol; 1995 Jan; 50(1):6-10. PubMed ID: 7834978
[TBL] [Abstract][Full Text] [Related]
16. Contrast-enhanced ultrasound in association with serum biomarkers for differentiating combined hepatocellular-cholangiocarcinoma from hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
Yang J; Zhang YH; Li JW; Shi YY; Huang JY; Luo Y; Liu JB; Lu Q
World J Gastroenterol; 2020 Dec; 26(46):7325-7337. PubMed ID: 33362387
[TBL] [Abstract][Full Text] [Related]
17. Contrast-enhanced MR imaging of intrahepatic cholangiocarcinoma: pathologic correlation study.
Murakami T; Nakamura H; Tsuda K; Ishida T; Tomoda K; Hori S; Monden M; Kanai T; Wakasa K; Sakurai M
J Magn Reson Imaging; 1995; 5(2):165-70. PubMed ID: 7766977
[TBL] [Abstract][Full Text] [Related]
18. Intrahepatic cholangiocarcinoma: MRI and pathologic correlation in 14 patients.
Vilgrain V; Van Beers BE; Flejou JF; Belghiti J; Delos M; Gautier AL; Zins M; Denys A; Menu Y
J Comput Assist Tomogr; 1997; 21(1):59-65. PubMed ID: 9022771
[TBL] [Abstract][Full Text] [Related]
19. DCE-MRI based radiomics nomogram for preoperatively differentiating combined hepatocellular-cholangiocarcinoma from mass-forming intrahepatic cholangiocarcinoma.
Zhou Y; Zhou G; Zhang J; Xu C; Zhu F; Xu P
Eur Radiol; 2022 Jul; 32(7):5004-5015. PubMed ID: 35128572
[TBL] [Abstract][Full Text] [Related]
20. Predictors of intrahepatic cholangiocarcinoma in cirrhotic patients scanned by gadobenate dimeglumine-enhanced magnetic resonance imaging: diagnostic accuracy and confidence.
Quaia E; Angileri R; Arban F; Gennari AG; Cova MA
Clin Imaging; 2015; 39(6):1032-8. PubMed ID: 26278014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
